NYSEARCA:IBRN iShares Neuroscience and Healthcare ETF (IBRN) Price, Holdings, & News → Discover little-known stocks with HUGE potential to soar in 2024 (From StockWireNews) (Ad) Free IBRN Stock Alerts $23.57 +0.27 (+1.16%) (As of 05/31/2024 ET) Add Compare Share Share Today's Range$23.39▼$23.6450-Day Range$22.69▼$25.5752-Week Range$19.08▼$26.90Volume2,193 shsAverage Volume678 shsMarket Capitalization$3.54 millionAssets Under Management$3.49 millionDividend Yield0.06%Net Expense Ratio0.47% Stock AnalysisStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Get iShares Neuroscience and Healthcare ETF alerts: Email Address About iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN)The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.Read More IBRN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBRN ETF News HeadlinesMay 30 at 2:10 AM | americanbankingnews.comiShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Trading Down 1.7%See More Headlines Receive IBRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Neuroscience and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssueriShares Fund NameiShares Neuroscience and Healthcare ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:IBRN Inception Date8/24/2022 Fund ManagerJennifer Hsui, Greg Savage, Paul Whitehead, Amy Whitelaw WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYSE FactSet Global Neuro Biopharma and MedTech Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings63 Fund Statistics Assets Under Management$3.49 million Average Daily Volume$0.00 Discount/Premium0.03% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorBlackRock Fund Advisors CustodianState Street Bank and Trust Company DistributorBlackRock Investments, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerFlow Traders Miscellaneous Outstanding Shares150,000Beta1.06 Creation Unit50,000 Creation Fee$350.00 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Ad Wealthpin ProDo This Before July 30 2024 To Claim Trump’s Gift In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024. iShares Neuroscience and Healthcare ETF ExpensesTypeIBRNTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.47%0.57%0.54%0.51%0.51%Other Expenses0.00%0.72%0.54%0.64%0.58%Total Expense0.47%0.72%0.70%0.74%0.70%Fee Waiver0.00%-0.76%-0.55%-0.68%-0.56%Net Expense0.47%0.59%0.60%0.58%0.58% iShares Neuroscience and Healthcare ETF (IBRN) Holdings & ExposureTop 10 IBRN HoldingsPTC Therapeutics(NASDAQ:PTCT)Holding Weight: 5.45%Neurocrine Biosciences(NASDAQ:NBIX)Holding Weight: 5.01%Cerevel Therapeutics(NASDAQ:CERE)Holding Weight: 4.75%Axonics(NASDAQ:AXNX)Holding Weight: 4.66%Sarepta Therapeutics(NASDAQ:SRPT)Holding Weight: 4.63%Biogen(NASDAQ:BIIB)Holding Weight: 4.62%Intra-Cellular Therapies(NASDAQ:ITCI)Holding Weight: 4.35%argenx(NASDAQ:ARGX)Holding Weight: 4.30%Xenon Pharmaceuticals(NASDAQ:XENE)Holding Weight: 3.85%Alkermes(NASDAQ:ALKS)Holding Weight: 3.72%IBRN Sector ExposureIBRN Industry ExposureFull Holdings Details Similar ETFsProShares S&P Kensho Cleantech ETFNYSEARCA:CTEXHorizon Kinetics Energy and Remediation ETFNYSEARCA:NVIRAdvisorShares Alpha DNA Equity Sentiment ETFNYSEARCA:SENTProShares Ultra Nasdaq Cybersecurity ETFNASDAQ:UCYBVolshares Large Cap ETFNYSEARCA:VSL IBRN ETF - Frequently Asked Questions How have IBRN shares performed in 2024? iShares Neuroscience and Healthcare ETF's stock was trading at $26.23 on January 1st, 2024. Since then, IBRN shares have decreased by 10.1% and is now trading at $23.5741. View the best growth stocks for 2024 here. What does IBRN invest in? iShares Neuroscience and Healthcare ETF is a equity fund issued by iShares. IBRN focuses on theme investments and follows the NYSE FactSet Global Neuro Biopharma and MedTech Index. The fund's investments total to approximately $3.49 million assets under management. What stocks does iShares Neuroscience and Healthcare ETF hold? IBRN invests in 63 holdings. Some of the stocks in their portfolio include PTC Therapeutics (PTCT), Neurocrine Biosciences (NBIX), Cerevel Therapeutics (CERE), Axonics (AXNX), Sarepta Therapeutics (SRPT), Biogen (BIIB), Intra-Cellular Therapies (ITCI), argenx (ARGX), Xenon Pharmaceuticals (XENE) and Alkermes (ALKS). What is the management fee for iShares Neuroscience and Healthcare ETF? iShares Neuroscience and Healthcare ETF's management fee is 0.47% and has no other recorded expenses or fee waivers. The net expense ratio for IBRN is 0.47%. How do I buy shares of iShares Neuroscience and Healthcare ETF? Shares of IBRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:IBRN) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders41 banks launch ‘crypto dollar’Stansberry ResearchShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeBill Clinton Backing Biden Replacement???The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin Pro Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.